Journal Home
Search for

Volume 120, Issue 3, Supplement, Pages A2-A4 (September 2007)


View previous. 2 of 3 View next.

Table of Contents

Article Outline

Allergen Immunotherapy: A Practice Parameter Second Update

Allergen Immunotherapy: A Practice Parameter Second Update 

return to Article Outline

PrefaceS27

Algorithm and annotations for immunotherapyS28

Immunotherapy glossaryS31

IntroductionS33

Summary statementsS33

Mechanisms of immunotherapyS38

Allergen extractsS38

Cross-reactivity of allergen extractS39

Efficacy of immunotherapyS41

Allergic rhinitis, allergic asthma, and stinging insect hypersensitivityS41

Food allergy, urticaria, and atopic dermatitisS42

Measures of efficacyS43

Safety of immunotherapyS43

Reaction ratesS43

Timing of anaphylactic reactions to immunotherapy injectionsS44

β-Adrenergic blocking agentsS45

ContraindicationsS45

Reducing the risk of anaphylaxis to immunotherapy injectionsS46

Patient selectionS46

Clinical indicationsS46

Special precautions in patients with asthmaS47

Clinical indications for VITS48

Allergen selection and handlingS48

Allergen selectionS48

Specific allergensS49

Mixing of extractsS50

Allergen immunotherapy extract handlingS52

Immunotherapy schedules and dosesS53

Recommended dosesS54

Effect of dilution on doseS55

Dilutions of the maintenance concentrateS56

Labeling dilutionsS56

Individualized treatment vialsS57

Starting dosesS57

Frequency of build-up injectionsS57

Dose adjustments for systemic reactionsS58

Reductions during periods of exacerbation of symptomsS58

Dose adjustments for late injectionsS58

Cluster schedulesS58

Rush schedulesS58

Systemic reactions and rush schedulesS58

Premedication and weekly immunotherapyS59

Premedication with cluster and rush immunotherapyS59

Maintenance schedulesS59

Continuing careS59

Duration of treatmentS60

Location of allergen immunotherapy administrationS61

Physician's officeS61

Other locationsS62

Special considerations in immunotherapyS63

Allergen immunotherapy in childrenS63

Immunotherapy in pregnancyS64

Immunotherapy in the elderly patientS64

Immunotherapy in patients with immunodeficiency and autoimmune disordersS64

Alternative routes of immunotherapyS64

Sublingual and oral immunotherapyS64

Intranasal immunotherapyS66

Immunotherapy techniques that are not recommendedS66

Future trends in immunotherapyS66

AppendixS75

 All rights reserved. No part of this publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher. Statements and opinions expressed in the articles and communications herein are those of the author(s) and not necessarily those of the Editor, publisher, or the American Academy of Allergy, Asthma & Immunology. The Editor, publisher, and the American Academy of Allergy, Asthma & Immunology disclaim any responsibility or liability for such material and do not guarantee, warrant, or endorse any product or service advertised in this publication nor do they guarantee any claim made by the manufacturer of such product or service.

PII: S0091-6749(07)01375-9

doi:10.1016/S0091-6749(07)01375-9


View previous. 2 of 3 View next.